# SANCUSO

NDC: 66220-637
Generic name: granisetron
Labeler / Manufacturer: Cumberland Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: PATCH
Routes: TRANSDERMAL
Marketing started: 20240716

FDA application: NDA022198

## Active ingredients

- GRANISETRON: 3.1 mg/24h

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66220-637"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66220-637
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7379369a-03df-4ec3-8f2e-66645cc736d8